Cary Street Partners Investment Advisory’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$787K Sell
2,175
-226
-9% -$77.4K 0.16% 140
2026
Q1
$845K Buy
2,401
+403
+20% +$144K 0.22% 109
2025
Q4
$654K Buy
1,998
+113
+6% +$35.8K 0.18% 131
2025
Q3
$532K Buy
1,885
+412
+28% +$119K 0.22% 102
2025
Q2
$411K Buy
1,473
+111
+8% +$31.4K 0.2% 115
2025
Q1
$424K Buy
1,362
+948
+229% +$280K 0.24% 106
2024
Q4
$108K Sell
414
-11,835
-97% -$3.51M 0.07% 254
2024
Q3
$3.95M Buy
12,249
+1,341
+12% +$439K 0.15% 160
2024
Q2
$3.41M Buy
10,908
+1,498
+16% +$440K 0.14% 172
2024
Q1
$2.68M Buy
9,410
+172
+2% +$50.3K 0.11% 199
2023
Q4
$2.66M Buy
9,238
+584
+7% +$159K 0.13% 189
2023
Q3
$2.33M Buy
8,654
+243
+3% +$60.6K 0.13% 195
2023
Q2
$1.87M Sell
8,411
-15
-0.2% -$3.48K 0.12% 184
2023
Q1
$2.04M Buy
8,426
+248
+3% +$60.9K 0.15% 163
2022
Q4
$2.15M Buy
8,178
+196
+2% +$52.5K 0.16% 151
2022
Q3
$1.8M Buy
7,982
+2,244
+39% +$544K 0.15% 159
2022
Q2
$1.4M Buy
5,738
+4,285
+295% +$1.05M 0.12% 178
2022
Q1
$351K Buy
1,453
+263
+22% +$60.4K 0.1% 188
2021
Q4
$268K Sell
1,190
-82
-6% -$17.3K 0.07% 221
2021
Q3
$270K Sell
1,272
-15
-1% -$3.45K 0.09% 198
2021
Q2
$314K Buy
1,287
+25
+2% +$6.15K 0.1% 185
2021
Q1
$314K Sell
1,262
-3,987
-76% -$951K 0.13% 158
2020
Q4
$1.21M Sell
5,249
-4,858
-48% -$1.12M 0.23% 106
2020
Q3
$2.57M Buy
10,107
+8,848
+703% +$2.19M 0.54% 57
2020
Q2
$296K Sell
1,259
-143
-10% -$32.6K 0.42% 75
2020
Q1
$284K Sell
1,402
-209
-13% -$45.7K 0.66% 43
2019
Q4
$388K Buy
+1,611
New +$355K 0.43% 66

Other funds holding AMGN

Cary Street Partners Investment Advisory's AMGN Position: Q2 2026 in Review

Cary Street Partners Investment Advisory reduced its Amgen (AMGN) stake by 9.4% in Q2 2026, selling an estimated $77.4K and leaving 2,175 shares worth $787K. The position accounts for 0.16% of the portfolio, ranked #140.

Cary Street Partners Investment Advisory first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.95M in Q3 2024. 1,788 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cary Street Partners Investment Advisory held 2,175 shares of Amgen worth $787K as of Q2 2026.
  • Cary Street Partners Investment Advisory sold 226 Amgen shares in Q2 2026, an estimated $77.4K.
  • Amgen made up 0.16% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #140 holding.
  • Cary Street Partners Investment Advisory first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
  • Cary Street Partners Investment Advisory's Amgen position peaked at $3.95M in Q3 2024.
  • 1,788 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.